Roquefort Therapeutics plc (LON: ROQ)
London
· Delayed Price · Currency is GBP · Price in GBX 3.700
-0.100 (-2.63%)
Jan 23, 2025, 2:15 PM BST
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 5.16 million as of January 23, 2025. Its market cap has decreased by -44.91% in one year.
Market Cap
5.16M
Enterprise Value
5.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.70
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 5.16M, an increase of 135.85%. That is a compound annual growth rate of 25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 5.16M | -6.17% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.80B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |